The Board of Directors of CanSino Biologics Inc. has authorized a buyback plan on January 23, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 HKD | +0.95% |
|
+2.58% | -18.81% |
Jun. 27 | CanSino Biologics Inc. Approves Election of Chi Shing LI as Non-Executive Director | CI |
Jun. 24 | Cansino Biologics' Senior Management to Boost Stakeholding | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 955M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.76% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+4.00% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- CanSino Biologics Inc. authorizes a Buyback Plan.